Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Product Information [Line Items]        
Insured limit $ 250,000   $ 250,000  
Advertising expense 22,000 $ 0 28,000 $ 3,000
Selling, General and Administrative Expenses [Member] | Revision of Prior Period, Adjustment [Member]        
Product Information [Line Items]        
Reclassified patent expenses and annuity costs   $ 59,000   $ 101,000
Diagnostic Test [Member]        
Product Information [Line Items]        
Revenues 7,000   8,000  
Cytometry Services [Member]        
Product Information [Line Items]        
Revenues 3,000   3,000  
U.S. Department Of Defense [Member]        
Product Information [Line Items]        
Revenues $ 10,000   $ 10,000